• 
• http://www.nature.com/mp/
• Editor: Julio Licinio, MD
• Volume 13: 12 issues per year
• ISSN: 1359-4184
• EISSN: 1476-5578
• Impact factor : 10.9*
• Impact ranking: 2/94 in Psychiatry; 7/211 in Neuroscience; 13/263 in Biochemistry and Molecular Biology*
• Date Established: 1996
• Published on behalf of:

Aims and Scope:

Molecular Psychiatry publishes work aimed at elucidating biological mechanisms underlying psychiatric disorders and their treatment. The emphasis is on studies at the interface of pre-clinical and clinical research, including studies at the cellular, molecular, integrative, clinical, imaging and psychopharmacological levels.

Readership:

All researchers and clinicians in psychiatry, neuroscience and related areas, such as neurology, neurosurgery, behavioural medicine, and genetics as well as clinical and experimental psychologists will be interested in Molecular Psychiatry.

Molecular Psychiatry provides:

• Original Articles - high quality, peer reviewed, authoritative research articles communicating the most significant findings to a broad multi-disciplinary readership.
• News & Commentary - concise overviews of new and original work.
• Letters to the Editor - scientific correspondence relating to any of the following:
• short reports of a novel, topical finding of general interest, comments on original research papers or other technical material published in Molecular Psychiatry
• communication of preliminary results of exceptional interest that are particularly topical and relevant, and for which fast publication is essential
• a scientific perspective on a topical issue of international public interest.
• Perspectives - summaries of development in fast-moving areas of interest to the readers of Molecular Psychiatry.
• Feature Reviews - top international researchers reveal cutting-edge advances in their respective areas of expertise providing readers with an authoritative overview of new developments in their fields.
• Immediate Communications - definitive studies of high merit, exceptional significance and novelty, which warrant rapid dissemination.

What makes Molecular Psychiatry stand apart?

• Original Research - with the goal of providing a forum for integrating molecular medicine with clinical psychiatry. Molecular Psychiatry publishes hypotheses-driven, high-quality work in molecular, cellular or integrative neuroscience as well as clinical research in psychiatry, including genetics, pathophysiology, imaging, and psychopharmacology.
• The only journal in the top 4th percentile for both Psychiatry and Neuroscience - With an impact factor placing it the top ten journal ranking for both subject areas, Molecular Psychiatry is ranked 2 out of the total 94 journals in Psychiatry and 9 out of 200 in Neuroscience.
• Pre-clinical and clinical coverage - The wide coverage this journal offers in the fields of molecular medicine and psychiatry make it a must read journal for practicing clinicians as well as any researchers.
• Accessibility to a Broad Readership - articles published in Molecular Psychiatry are accompanied by supplementary information in the form of text, figures or videos. This allows readers to tailor information to suit their individual needs.
• Advanced User Functionality - the clean design of Molecular Psychiatry facilitates easy navigation and retrieval of information for users, including those using assistive technology.

Online features and site license access:

• Online archive available back to January 1997.
• A site license provides access to all content published during the supply period. Access is granted to a further rolling four-year archive during the supply period. Archive content is freely available after five years.
• Users have access to all the online features of nature.com. Find out more >>
• Site license customers will benefit from the services available. Find out more >>
• Indexed in Medline (PubMed), Neuroscience Citation Index, Current Contents, SciSerach, Science Citation Index, Research Alert, EMBASE, SCI Expanded, Current Contents Life Sciences and PSYCINFO.

*2007 Journal Citation Report (Thomson Reuters, 2008)